Akamai CTO sells 3,500 shares in plan trade

Akamai Technologies Chief Technology Officer Robert Blumofe reported an open-market sale of 3,500 shares of common stock at $108 per share on February 13, 2026.

Accepted by SEC EDGAR 02/13/2026 - 04:20 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Akamai Technologies Chief Technology Officer Robert Blumofe reported an open-market sale of 3,500 shares of common stock at $108 per share on February 13, 2026. After the sale, he directly owned 14,574 shares.

He also held 103.347 shares indirectly through a 401(k) plan as of February 12, 2026. The sale was made under a Rule 10b5-1 trading plan adopted on March 12, 2025.

Insider Trade Summary

Net Seller: 3,500 shares

Net Sell 1 txn

Insider Blumofe Robert

Role Chief Technology Officer

Sold 3,500 shs ($378K)

Share of Position Sold 19.4%

Type	Security	Shares	Price	Value
Sale	Common Stock	3,500	$108.00	$378K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 14,574 shares (Direct); Common Stock — 103.347 shares (Indirect, By 401(k) Plan)

Holdings Before and After: Common Stock, 18,074 to 14,574 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.
2. F2. As of February 12, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Akamai (AKAM) report for CTO Robert Blumofe?

Akamai’s Chief Technology Officer Robert Blumofe sold 3,500 shares of common stock in an open-market transaction at $108 per share on February 13, 2026. The transaction was disclosed in a Form 4 insider filing with detailed post-transaction share ownership.

At what price did Akamai (AKAM) CTO Robert Blumofe sell his shares?

Robert Blumofe sold 3,500 Akamai common shares at $108 per share. This open-market sale was recorded on February 13, 2026 and reported in a Form 4, which also shows his remaining direct and indirect share holdings after the transaction.

How many Akamai (AKAM) shares does CTO Robert Blumofe own after the reported sale?

After the sale, Robert Blumofe directly owns 14,574 Akamai common shares. In addition, he has 103.347 shares held indirectly through a 401(k) plan as of February 12, 2026, according to the ownership amounts disclosed in the Form 4 filing.

Was the Akamai (AKAM) CTO’s share sale under a Rule 10b5-1 plan?

Yes. The filing states the sale was made under a Rule 10b5-1 trading plan adopted by Dr. Blumofe on March 12, 2025. Such plans allow pre-scheduled trades, providing structure for insiders to sell shares over time under predetermined instructions.

What type of Form 4 transaction code was used in the Akamai (AKAM) insider trade?

The transaction used code “S,” indicating a sale in the open market or a private transaction. The Form 4 describes this as an open-market sale of 3,500 common shares at $108 per share by Akamai’s Chief Technology Officer, Robert Blumofe.

Does the Akamai (AKAM) Form 4 show any indirect holdings for the CTO?

Yes. In addition to direct holdings, the Form 4 reports 103.347 Akamai common shares held indirectly through a 401(k) plan as of February 12, 2026. This is categorized as indirect ownership separate from his 14,574 directly held shares after the reported sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blumofe Robert

(Last) (First) (Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		S(1)		3,500	D	$108	14,574	D
Common Stock								103.347(2)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.

2. As of February 12, 2026.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.